A generic alternative indicated for Neurology. Regulating calcium channel activity supports the stability of vascular tissues and reduces the frequency of recurring physical distress.
A calcium channel blocker intended to manage migraine frequency and developed to alleviate vertigo by targeting abnormal vestibular and vascular activity.
Mechanism of Action
It inhibits the influx of calcium into cells. This prevents the narrowing of brain blood vessels and protects nerve cells from excessive calcium overload.
Route of Administration
Oral
Onset Time
Several weeks
Duration
24 hours
Contraindications
Parkinson's disease, History of depression, Allergy to flunarizine
Severe Adverse Events
Depression, Extrapyramidal symptoms (tremors, stiffness), Tardive dyskinesia, Severe sedation
Information for Flunarizine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
